New chambers designed to provide optimum uniformity for stable environmental conditions
Thermo Scientific Environmental Chambers use a unique airflow system for advanced temperature control.
A new range of 230-volt environmental chambers, designed to provide highly stable environmental conditions, is now available in Europe, Africa, Latin America and the Asia Pacific region.
The newly CE-marked range of Thermo Scientific Environmental Chambers provide temperature control above and below ambient for drug stability testing, shelf-life testing, insect studies or controlled storage. There are two models available in the range: the wide temperature units with humidity (available in 311 L and 821 L) and a heat-only model (available in 821 L) that is tailored for large-scale clinical applications and microbiology. For applications that require close control of a CO2 environment, there’s an optional infrared CO2 package available that can be added to the wide temperature model.
The interior of the environmental chambers is designed for stability. The horizontal laminar airflow system enables ideal temperature uniformity and fast recovery rates, which provide an optimal growth and testing environment, even with large product loads or heat-generating equipment.
The environmental chambers feature a broad temperature range spanning from 0 to 60 degrees Celsius and the relative humidity is easily controlled to meet the needs of different applications. Importantly, the chambers meet certain compliance and regulatory requirements, including international conference on harmonization (ICH) guidelines for drug substance and product storage testing.
“Thermo Fisher Scientific has sold environmental chambers for more than 25 years in the US, and we are thrilled to now introduce this product to Europe,” said Konrad Knauss, global product manager, Thermo Fisher Scientific. “Designed with the end user in mind, this series of environmental chambers is highly flexible and suited to a broad range of application needs, meaning that it fits a laboratory’s needs now as well as in the future.”
The rugged construction of the chambers promotes a long lifespan and provides a flexible and cost-effective solution for researchers. The chambers connect to standard monitoring systems for easy internal and regulatory product documentation and can be supplemented with accessories and options for many specific applications.
Related News
-
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease.
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines.
-
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries.
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement.